Skip Navigation
Skip to contents

Urogenit Tract Infect : Urogenital Tract Infection

OPEN ACCESS

Author Index

Page Path
HOME > Browse Articles > Author Index
Search
Soo Bang Ryu 7 Articles
Prophylactic Effectiveness of Second Generation Cephalosporin According to Prostatic Operation Methods
Seong Woong Na, Eu Chang Hwang, Seung Il Jung, Dong Deuk Kwon, Kwangsung Park, Soo Bang Ryu
Korean J Urogenit Tract Infect Inflamm 2011;6(2):171-177.   Published online October 31, 2011
AbstractAbstract PDF
"Purpose: There is no definitive standard concerning the use of prophylactic antibiotics for prostatic operations, except for transurethral resection of prostate (TUR-P). This study prospectively investigated the prophylactic effectiveness of a second generation cephalosporin according to prostatic operation method. Materials and Methods: From October 2010 to January 2011, prostatic operations were conducted for 67 patients: group I (radical prostatectomy, n=18), group II (TUR-P, n=38), group III (laser TUR-P, n=11) for 11: group III). Prophylactic antibiotics were intravenously administered beginning 1 hour preoperatively and orally with several days postoperatively. Prophylactic effectiveness was evaluated by comparison of urine analysis and presence of bacteriuria. Results: In group I, no patient had preoperative Foley catheter installation, and mean antibiotic prescription period pre- and post-operatively was 5.83 days and 6.94 days. Five group I patients (27.8%) displayed bacteriuria. In group II, 9 patients had preoperative Foley catheter installation and mean antibiotic prescription period was 3.76 days and 5.68 days, respectively. Five patients (13.2%) had postoperative bacteriuria; two in preoperative catheterized patients and three in preoperative non-catheterized patients. In group III, mean antibiotic prescription period was 1.73 days and 5.09 days, respectively. There was no postoperative bacteriuria. Conclusions: Prophylactic use of a second generation cephalosporin for prostatic operation, except laser TUR-P, was limited in preventing postoperative pyuria with bacteriuria. There was a tendency of higher occurrence of postoperative bacteriuria in patients with preoperative Foley catheter installation."
  • 6 View
  • 0 Download
Close layer
Clinical Features of Bacteremia Caused by Ciprofloxacin-Resistant Bacteria after Transrectal Ultrasound-Guided Prostate Biopsy
Bo Sung Shin, Eu Chang Hwang, Seung Il Jung, Dong Deuk Kwon, Kwangsung Park, Soo Bang Ryu, Jin Woong Kim
Korean J Urogenit Tract Infect Inflamm 2011;6(1):61-66.   Published online April 30, 2011
AbstractAbstract PDF
"Purpose: Fluoroquinolone is considered the prophylactic antibiotic of choice for Transrectal ultrasound (TRUS)-guided biopsy. However, failure of quinolone prophylaxis due to emerging quinolone-resistant enterobacteriae has been increasing. We reviewed bacteremia cases after TRUS-guided biopsy to identify antibiotic-resistant bacterial strains with the objective to prevent urosepsis. Materials and Methods: A total of 2,348 patients underwent TRUS-guided biopsy at our institution between January 2004 and December 2009. All patients received intravenous ciprofloxacin for prophylaxis. We retrospectively evaluated patients who developed infectious symptoms, such as fevers and chills. Results: Eleven (0.4%) of 2,348 patients developed infectious symptoms. Escherichia coli was the pathogen responsible for post-biopsy infections occurring in a; 11 (100%) patients with positive blood cultures, which confirmed ciprofloxacin-resistant E. coli, with one isolate producing extended-spectrum beta lactamase. Ten out of 11 E. coli isolates (91%) were resistant to ampicillin and 9 of 11 E. coli isolates (82%) were resistant to gentamicin. Ten out of 11 E. coli isolates (91%) were susceptible to third generation cephalosporins. All such patients were admitted to the hospital and treated with a third generation cephalosporin. One patient who habored an E. coli isolate producing extended-spectrum beta-lactamase received imipenem. Conclusions: Ciprofloxacin is effective in reducing infectious complications. However, recently, bacteremiccases are increasing due to ciprofloxacin resistant E. coli. For patients with infectious symptoms after transrectal prostate biopsy, early antibiotics change, including third generation cephalosporins, are recommended to prevent urosepsis."
  • 4 View
  • 0 Download
Close layer
Fournier’s Gangrene: Six Years of Experience with 33 Patients and Validity of the Fournier’s Gangrene Severity Index Score in Korean Patients
Eu Chang Hwang, Seong Woong Na, Young Jung Kim, Jun Seok Kim, Sun-Ouck Kim, Seung Il Jung, Dong Deuk Kwon, Kwangsung Park, Soo Bang Ryu, Lu Ji Wan
Korean J Urogenit Tract Infect Inflamm 2010;5(2):199-206.   Published online October 31, 2010
AbstractAbstract PDF
"Purpose: To identify predictive factors of survival in patients with Fournier’s gangrene (FG), and to determine the validity of the Fournier’s Gangrene Severity Index Score (FGSIS) in Korean patients. Materials and Method: Thirty-three patients with FG were enrolled. Data were collected regarding medical history, symptoms, physical examination findings, admission laboratory tests, and the extent of body surface area involved (%). The FGSIS, which was developed to assign a numerical score that describes the disease acuity, was used in our study. The data were assessed based on whether or not the patient had survived. Results: Of the 33 patients, 16 survived (48.5%, Group I) and 17 died (51.5%, Group II). Isolated FGSIS and admission laboratory parameters that were statistically different in the two groups included heart rate (p=0.009), white blood cell count (WBC; p=0.035), and serum calcium (p=0.001). The mean body surface area in Group II was statistically different from that of Group I (6.4% vs. 2.4%, p=0.001). The mean FGSIS for groups I and II was 6.6±3.7 and 8.2±4.1, respectively (p=0.26). Based on univariate regression analysis, disease severity had no correlation with the FGSIS. However, isolated parameters, including heart rate, WBC count, serum total calcium level, and the extent of body surface area involved was associated with disease severity. Conclusions: Although the FGSIS was not shown to be a predictive factor for disease severity, metabolic parameters and the extent of body surface area involved appeared to be important factors for predicting FG severity."
  • 8 View
  • 0 Download
Close layer
Pyeloureteritis Cystica accompanied by Nonfunctioning Kidney
Jun Back Park, Chang Min Im, Seung IL Jung, Chan Choi, Taek Won Kang, Dong Deuk Kwon, Kwangsung Park, Soo Bang Ryu
Korean J Urogenit Tract Infect Inflamm 2009;4(2):224-227.   Published online October 31, 2009
AbstractAbstract PDF
Pyeloureteritis cystica is a rare cystic disease formed in the mucosa or submucosa of the renal pelvis and ureter caused by chronic inflammation and irritation, and characterized by multiple filling defects noted on the contrast imaging. The clinical course is usually slow, but manifests if the lesionscause infection or obstruction. Stones are further complication to the disease. We report a case of 69-year-old woman with right flank pain, who had an pyeloureteritis cystica withnonfunctioning kidney caused by proximal ureter stone. The diagnosis was made after nephroureterectomy, followed by pathologic examination.
  • 6 View
  • 0 Download
Close layer
Retroperitoneal Fibrosis with Spontaneous Subcapsular Renal Hemorrhage Treated with Medical Thearpy
Eu Chang Hwang, Ho Suck Chung, Chang Min Im, Seung Il Jung, Dong Deuk Kwon, Kwangsung Park, Soo Bang Ryu, Jun Eul Hwang1
Korean J Urogenit Tract Infect Inflamm 2009;4(1):86-88.   Published online April 30, 2009
AbstractAbstract PDF
Spontaneous subcapsular renal hemorrhage is relative uncommon. The literature suggests that the majority causes for this phenomenon associated with disease of the kidney, blood vessel disease, blood dyscrasia. We report a unique case of retroperitoneal fibrosis combined with subcapsular renal hemorrhage. The patient was successfully treated with medical therapy.
  • 7 View
  • 0 Download
Close layer
Bacteremia Caused by Acinetobacter Baumannii during the Treatment of Staghorn Calculi
Seung Il Jung, Kyung-Chul Son, Taek Won Kang, Dong Deuk Kwon, Kwangsung Park, Soo Bang Ryu
Korean J Urogenit Tract Infect Inflamm 2008;3(1):116-119.   Published online April 30, 2008
AbstractAbstract PDF
Acinetobacter baumannii, a gram-negative, ubiquitous bacteria present in the soil, water and on the skin surface of human beings and animals, is responsible for bronchopneumonia and bacteremia in immuno- compromised and severely illed people, but rarely represents a problem in healthy individuals. We report a case of bacteremia due to Acinetobacter baumannii in a 45-year-old women who underwent percutaneous nephrolithotomy for staghorn calculi.
  • 6 View
  • 0 Download
Close layer
Multicenter Clinical Outcome of Gatifloxacin for Chronic Prostatitis (NIH Category II or IIIa) in Korea
Sang Don Lee, Seung Ju Lee, Tae Kon Hwang, Duck Ki Yoon, Kyu Sung Lee, Luck Hee Sung, Myung Soo Choo, Bong Suk Shim, In Rae Cho, Min Eui Kim, Soo Bang Ryu, Chul Sung Kim, Young Gon Kim, Chun Il Kim, Hyun Yul Rhew, Yong-Hyun Cho
Korean J Urogenit Tract Infect Inflamm 2007;2(1):53-60.   Published online May 31, 2007
AbstractAbstract PDF
"Purpose: The objective of this study was to investigate the efficacy and safety of gatifloxacin for patients with chronic prostatitis (NIH category II or IIIa) in Korean urologic practice. Materials and Methods: A total of 16 outpatient urology clinics at tertiary care medical centers in Korea participated. Gatifloxacin (400 mg/day) treatment (S.D.) of 149 patients (20 patients with category II and 129 patients with category IIIa) with prostatitis (mean age 45.8±13.3 years) was carried out for 41.7 (33.1) days. A 4-glass test according to Meares and Stamey or two glass test was carried out at study entry and one month after the end of treatment. Clinical response, safety and bacteriological response were assessed before treatment (within 48 hours of initiation of the study medication) and at one month after treatment completion. Results: In a otal of 149 patients, the total NIH-CPSI score was significantly reduced from 20.5 to 10.0 (response rate 86.7%; 95% CI 80.2-93.2%) (p<0.05). Sub-scores of pain, urinary symptoms and impact on the quality of life were also significantly reduced from 8.9 to 3.8 (response rate 83.8%; 95% CI 76.8-90.9%), from 4.2 to 2.0 (response rate 73.3%; 95% CI 64.9-81.8%) and from 7.4 to 4.2 (response rate 79.0%; 95% CI 71.3-86.8%), respectively (p<0.05). In terms of the overall clinical efficacy assessment by investigators, out of 149 patients with prostatitis, 71.2% were assessed to be responders. Bacteriological studies in expressed prostatic secretion (EPS) or post prostate massage urine (VB3) at 1 month after treatment completion demonstrated that the overall eradication rates of pathogens was 85% and the pyuria (≥10 WBC/HPF) rates in the NIH category II and IIIa were 35% and 18.6%, respectively (overall rate 20.8%). There were 16.1% of patients that presented with some adverse events considered by investigators to be related to the drug. The majority of adverse events were considered to be of mild (87.5%) or moderate (8.3%) intensity. Conclusions: These results suggest that gatifloxacin in Korean urologic practice is well tolerated and improves the clinical outcomes in the patientswith chronic prostatitis (NIH category II or IIIa)."
  • 8 View
  • 0 Download
Close layer

Urogenit Tract Infect : Urogenital Tract Infection
Close layer
TOP